Our Team
Dr. Vivek Rajagopal, CMO
Dr. Rajagopal is cofounder and CMO of Opus Medical Therapies. He is an Interventional Cardiologist at Piedmont Healthcare in Atlanta, GA and also served as founding CEO of Opus. Dr. Rajagopal earned his medical degree from the University of Michigan in Ann Arbor, Michigan. He completed his internship at the University of Washington in Seattle and his residency at Stanford University in Palo Alto, California. Dr. Rajagopal fulfilled a cardiology fellowship with the Cleveland Clinic Foundation in Cleveland, Ohio. He completed his undergraduate training at The Johns Hopkins University in Baltimore, Maryland.
Jaime Sarabia, CEO
Jaime Sarabia is cofounder and CEO of Opus Medical Therapies. Prior to Opus, Jaime was cofounder and CEO of 510 Kardiac Devices (acquired by Venus MedTech). Jaime was an early engineer at eValve (acquired by Abbott Vascular) responsible for designing and developing the Mitraclip device. Jaime also spent over 10 years in the clinical field working with physicians to start up Mitraclip sites around the world. Jaime has a BSME from the Massachusetts Institute of Technology and is an inventor on 20+ patents.
Yen Liao, COO
Yen Liao is cofounder and COO of Opus Medical Therapies. Prior to Opus, Yen was one of the first engineers at CardiAQ Valve Technologies (acquired by Edwards lifesciences) developing a first-generation TMVR device. Yen was also an early engineer at eValve (acquired by Abbott Vascular) developing the Mitraclip transseptal delivery system. He has a BSME from Tufts University and is an inventor on 15+ patents.
Al Raschdorf, CTO
Al Raschdorf is CTO of Opus Medical Therapies. Al was previously Chief Therapy Officer at Caisson Interventional (acquired by Livanova). Prior to Caisson, Al was an early engineer at eValve (aquired by Abbott Vascular). While at Abbott, Al supported Mitraclip cases around the world and was country manager of Italy. Al has a BSME from Cornell University, a MSME from Stanford University and is a named inventor on 20+ patents.